Aiying Zhang | Computational Neuroscience | Best Researcher Award

Assist. Prof. Dr. Aiying Zhang | Computational Neuroscience | Best Researcher Award

Assist. Prof. Dr. Aiying Zhang, University of Virginia, United States.

Dr. Aiying Zhang is a rising scholar in the field of mental health data science, currently serving as an Assistant Professor at the University of Virginia and a Faculty Member at the UVA Brain Institute. Her academic foundation spans statistics, biomedical engineering, and clinical biostatistics, acquired from esteemed institutions including USTC, Tulane University, and Columbia University. Her research focuses on developing advanced computational and statistical tools—such as graphical models and multimodal fusion—to decode complex brain data from imaging and genetics. She applies these innovations to better understand and predict psychiatric conditions such as schizophrenia and Alzheimer’s disease. Her work is distinguished by its interdisciplinary nature, translational relevance, and potential to reshape clinical approaches to mental health.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Aiying Zhang’s journey into the realm of data science and mental health research began with a strong foundation in quantitative sciences. She earned her Bachelor of Science degree in Statistics from the prestigious School for the Gifted Young at the University of Science and Technology of China (USTC) in 2014. Driven by a passion for biomedical innovation and its intersection with human health, she pursued a Ph.D. in Biomedical Engineering from Tulane University, which she completed in 2021. Her graduate years were marked by deep inquiry into statistical modeling and neuroimaging, laying the groundwork for her later interdisciplinary research. She further honed her expertise through postdoctoral training in Clinical Biostatistics and Psychiatry at Columbia University Irving Medical Center, where she blended statistical rigor with clinical insight.

💼 Professional Endeavors

Dr. Zhang is currently an Assistant Professor of Data Science at the University of Virginia, where she has been on the tenure-track faculty since August 2023. She also holds a concurrent position as a Faculty Member at the UVA Brain Institute, underscoring her active role in advancing brain research across institutional boundaries. Prior to her academic appointment at UVA, she served as a Research Scientist II at the New York State Psychiatric Institute, contributing to high-impact psychiatric research. Her professional journey also includes research assistantships at Tulane University and the University of Florida, roles in which she cultivated strong collaborative and translational research skills.

🧠 Contributions and Research Focus

Dr. Zhang’s research lies at the intersection of data science, neuroscience, and mental health. She specializes in developing advanced statistical and computational methodologies to investigate the biological underpinnings of psychiatric and neurodevelopmental disorders. Her work prominently features the use of graphical models—both directed and undirected—and machine learning techniques to analyze complex datasets, such as MRI, DTI, fMRI, MEG, and various genomic modalities including SNP and DNA methylation. Her research has contributed to a deeper understanding of conditions like schizophrenia, Alzheimer’s disease, obsessive-compulsive disorder, and anxiety disorders, through the lens of multimodal data fusion and integrative neurogenetics.

🧪 Innovation in Mental Health Data Science

A distinctive hallmark of Dr. Zhang’s scholarship is her innovative application of multimodal fusion techniques to disentangle the complexities of typical and atypical brain development. Her work leverages high-dimensional neuroimaging and genetic data to draw meaningful inferences about mental health trajectories. She is particularly focused on building interpretable models that bridge the gap between data and clinical insight, thereby enabling earlier and more precise diagnostics. By combining machine learning with biomedical expertise, her contributions pave the way for next-generation tools in psychiatry and neuroscience.

🏅 Accolades and Recognition

Throughout her academic and professional trajectory, Dr. Zhang has earned widespread respect for her analytical acumen and interdisciplinary collaborations. Her postdoctoral role at Columbia, a hub for clinical psychiatry and biostatistics, positioned her among leaders in the field and enriched her research portfolio with translational applications. Her selection as faculty at a leading institution like UVA further reflects recognition of her scholarly excellence and her potential to drive future innovations in mental health data science.

🌍 Impact and Influence

Dr. Zhang’s work has significant implications for both the scientific community and clinical practice. Her methods empower researchers and clinicians alike to draw meaningful patterns from multimodal datasets, thereby advancing precision psychiatry. Moreover, her collaborative efforts across biomedical engineering, statistics, and clinical disciplines have fostered integrative frameworks that extend beyond academic settings into real-world applications. Her contributions are helping to shape a more data-driven and personalized future in mental health care.

🔮 Legacy and Future Contributions

As she continues her academic journey, Dr. Zhang aims to expand her research frontiers by exploring dynamic brain-behavior associations and improving the interpretability of AI models in clinical contexts. With a commitment to mentorship and open science, she is building a legacy rooted in intellectual rigor, innovation, and societal relevance. Her future contributions are expected to not only deepen our understanding of mental health disorders but also inspire a new generation of data scientists dedicated to neuroscience and human well-being.

Publication

  • Leverage multimodal neuro-imaging and genetics to identify causal relationship between structural and functional connectivity and ADHD with Mendelian randomization
    C Ji, S Lee, S Sequeira, J Jin, A Zhang2025

 

  • Integrated brain connectivity analysis with fmri, dti, and smri powered by interpretable graph neural networks
    G Qu, Z Zhou, VD Calhoun, A Zhang, YP Wang2025

 

  • Altered hierarchical rank in intrinsic neural time-scales in autism spectrum disorder
    A Solomon, W Yu, J Rasero, A Zhang2025

 

  • A Privacy-Preserving Domain Adversarial Federated learning for multi-site brain functional connectivity analysis
    Y Zhang, L Wang, KJ Su, A Zhang, H Zhu, X Liu, H Shen, VD Calhoun, …2025

 

  • A Novel GNN Framework Integrating Neuroimaging and Behavioral Information to Understand Adolescent Psychiatric Disorders
    W Yu, G Qu, Y Kim, L Xu, A Zhang2025

 

  • A Bayesian incorporated linear non-Gaussian acyclic model for multiple directed graph estimation to study brain emotion circuit development in adolescence
    A Zhang, G Zhang, B Cai, TW Wilson, JM Stephen, VD Calhoun, YP Wang2024

 

  • Exploring hierarchical gradients of intrinsic neural timescales in mild cognitive impairment and Alzheimer’s disease
    A Zhang, K Wengler, X Zhu, G Horga, TE Goldberg, S Lee2024

 

  • Time‐varying dynamic Bayesian network learning for an fMRI study of emotion processing
    L Sun, A Zhang, F Liang2024

 

  • Altered hierarchical gradients of intrinsic neural timescales in mild cognitive impairment and Alzheimer’s disease
    A Zhang, K Wengler, X Zhu, G Horga, TE Goldberg, S Lee, …2024

 

  • Associations Between Brain Connectivity and Psychiatric Symptoms in Children: Insights into Adolescent Mental Health
    D Mutu, K Ji, X He, S Lee, S Sequeira, A Zhang2024

 

🧾 Conclusion

Dr. Zhang’s journey exemplifies a seamless integration of data science and neuroscience to address pressing mental health challenges. Her innovative use of multimodal data and machine learning not only contributes to scientific advancement but also enhances real-world clinical decision-making. As she continues to pioneer research at the intersection of computation and psychiatry, her influence is poised to grow, shaping the future of precision mental health care and empowering both academia and clinical practice through data-driven insights.

 

Irena Roterman | Computational Neuroscience | Best Researcher Award

Prof. Dr. Irena Roterman | Computational Neuroscience | Best Researcher Award

Prof. Dr. Irena Roterman, Jagiellonian University Medical College, Poland.

Prof. Irena Roterman-Konieczna is a distinguished scientist whose academic roots in theoretical chemistry and biochemistry evolved into groundbreaking contributions in bioinformatics. With a Ph.D. and habilitation in biochemistry, and a postdoctoral fellowship at Cornell University, she developed a unique perspective on protein structure and folding. Her most notable innovation is the Fuzzy Oil Drop (FOD) model, which simulates protein folding by incorporating environmental effects using a 3D Gaussian function to map hydrophobicity distribution. This model has wide applicability—from understanding membrane proteins and amyloids to analyzing domain-swapping and receptor anchoring.

Profile

Scopus

 

🎓 Early Academic Pursuits

Irena Roterman-Konieczna began her academic journey in theoretical chemistry at the prestigious Jagiellonian University, graduating from the Faculty of Chemistry in 1974. Her early interest in molecular structure and the physicochemical underpinnings of biological systems laid a strong foundation for her interdisciplinary career. She deepened her scientific expertise by earning a Ph.D. in biochemistry in 1984 from Nicolaus Copernicus Medical Academy in Krakow, focusing on the structure of the recombinant IgG hinge region. Her postdoctoral studies at Cornell University from 1987 to 1989, under the mentorship of Harold A. Scheraga, further shaped her academic development. There, she explored force fields used in prominent computational programs like AMBER, CHARMM, and ECEPP, bridging theoretical modeling with biomolecular reality.

🧬 Professional Endeavors in Bioinformatics

Throughout her career, Prof. Roterman-Konieczna has been at the forefront of bioinformatics, dedicating herself to unraveling the mysteries of protein structure and amyloid formation. Following her habilitation in biochemistry at the Jagiellonian University Faculty of Biotechnology in 1994 and the conferment of her professorial degree in medical sciences in 2004, she continued to pioneer innovative methods in structural bioinformatics. Her hallmark contribution, the Fuzzy Oil Drop (FOD) model, revolutionized the understanding of protein folding. The model uniquely incorporates environmental influence into folding simulations by using a 3D Gaussian function to describe hydrophobicity distribution—proposing that hydrophobic residues form a central core while hydrophilic residues remain exposed. This paradigm introduced a more realistic, dynamic framework for simulating in silico protein folding.

🧪 Contributions and Research Focus

Prof. Roterman-Konieczna’s research has explored how proteins behave not only in aqueous environments but also within membranes and under the influence of external force fields. By modifying the Gaussian-based FOD model, she extended its applicability to membrane proteins, enabling quantification of their anchoring mechanisms and mobility. Her investigations into chaperonins and domain-swapping phenomena further illustrate the power of her model to decode complex folding and protein-protein interactions. She introduced a dual-variable simulation function—accounting for both internal forces (non-bonded interactions within the protein chain) and external forces (environmental effects)—to guide structural transformation toward energy minima. These ideas are foundational in modern computational biology, where realistic folding predictions are critical for understanding disease mechanisms and therapeutic targeting.

📘 Scholarly Publishing and Intellectual Outreach

A prolific author, Prof. Roterman-Konieczna has made significant contributions to scientific literature. She has authored several influential books, many published in Open Access to promote knowledge sharing. These works include “Protein Folding In Silico” (Elsevier), “Systems Biology – Functional Strategies of Living Organism” (Springer), and “From Globular Proteins to Amyloids” (Elsevier, 2020). Her books elegantly communicate complex bioinformatic strategies, such as ligand binding site identification, protein-protein interactions, and computer-aided diagnostics. Moreover, her editorial leadership from 2005 to 2020 as Chief Editor of the journal Bio-Algorithms and Med-Systems cemented her influence in shaping interdisciplinary dialogues at the intersection of medicine, biology, and computation.

🏆 Accolades and Recognition

Prof. Roterman-Konieczna’s work has earned international acclaim. Notably, she is listed among the Top 2% scientists worldwide by Stanford University and Elsevier—a testament to her influential research and academic reputation. With 149 publications indexed in PubMed, her impact on the bioinformatics community is both broad and profound. Over the course of her career, she has also served as a mentor to 14 doctoral students, many of whom continue to contribute to research and innovation across various fields of biomedicine.

🌐 Impact and Influence

Her research has advanced global understanding of how proteins fold, interact, and misfold—a process central to neurodegenerative diseases such as Alzheimer’s. The FOD model continues to provide a computational lens for studying amyloid formation and supramolecular assemblies. Her model is also pivotal in studying receptor anchoring in membranes and exploring domain-swapping mechanisms critical to protein complex formation. By integrating thermodynamic theory, statistical modeling, and structural biology, her work bridges theoretical research with biomedical applications, pushing the boundaries of in silico experimentation.

🧭 Legacy and Future Contributions

Prof. Irena Roterman-Konieczna’s legacy is rooted in her visionary approach to molecular biology, championing models that blend computational precision with biological realism. Her commitment to open access publishing and academic mentoring reflects a deep dedication to inclusive, sustainable scientific progress. As systems biology and personalized medicine continue to evolve, her models and insights will remain cornerstones for future explorations in disease modeling, drug design, and molecular diagnostics. Her career exemplifies how interdisciplinary thinking and computational ingenuity can transform the life sciences, leaving a legacy that will guide future generations of scientists.

Publication

  • Title: Aquaporins as Membrane Proteins: The Current Status
    Authors: I.K. Roterman (Irena K.), K. Stapor (Katarzyna), D. Dułak (Dawid), G. Szoniec (Grzegorz), L. Konieczny (Leszek)
    Year: 2025

 

  • Title: DisorderUnetLM: Validating ProteinUnet for efficient protein intrinsic disorder prediction
    Authors: K. Kotowski (Krzysztof), I.K. Roterman (Irena K.), K. Stapor (Katarzyna)
    Year: 2025

 

  • Title: Protein folding: Funnel model revised
    Authors: I.K. Roterman (Irena K.), M. Slupina (Mateusz), L. Konieczny (Leszek)
    Year: 2024

 

  • Title: Domain swapping: a mathematical model for quantitative assessment of structural effects
    Authors: I.K. Roterman (Irena K.), K. Stapor (Katarzyna), D. Dułak (Dawid), L. Konieczny (Leszek)
    Year: 2024

 

  • Title: Chameleon Sequences─Structural Effects in Proteins Characterized by Hydrophobicity Disorder
    Authors: I.K. Roterman (Irena K.), M. Slupina (Mateusz), K. Stapor (Katarzyna), K. Gądek (Krzysztof), P. Nowakowski (Piotr)
    Year: 2024

 

  • Title: Transmembrane proteins—Different anchoring systems
    Authors: I.K. Roterman (Irena K.), K. Stapor (Katarzyna), L. Konieczny (Leszek)
    Year: 2024

 

  • Title: External Force Field for Protein Folding in Chaperonins─Potential Application in In Silico Protein Folding
    Authors: I.K. Roterman (Irena K.), K. Stapor (Katarzyna), D. Dułak (Dawid), L. Konieczny (Leszek)
    Year: 2024

 

  • Title: Structural features of Prussian Blue-related iron complex FeT of activity to peroxidate unsaturated fatty acids
    Authors: M. Lasota (Małgorzata), G. Zemanek (Grzegorz), O. Barczyk-Woźnicka (Olga), L. Konieczny (Leszek), I.K. Roterman (Irena K.)
    Year: 2024

 

  • Title: Editorial: Structure and function of trans-membrane proteins
    Authors: I.K. Roterman (Irena K.), M.M. Brylinski (Michal Michal), F. Polticelli (Fabio), A.G. de Brevern (Alexandre G.)
    Year: 2024

 

  • Title: Model of the external force field for the protein folding process—the role of prefoldin
    Authors: I.K. Roterman (Irena K.), K. Stapor (Katarzyna), L. Konieczny (Leszek)
    Year: 2024

 

🧠 Conclusion

Prof. Roterman-Konieczna’s career stands as a testament to how deep scientific insight and computational innovation can revolutionize biological understanding. Her FOD model not only enriches the study of protein dynamics but also provides a versatile framework for medical and pharmaceutical applications. With a legacy built on rigorous research, educational outreach, and academic leadership, her influence will continue to guide future advances in molecular biology, bioinformatics, and biomedical science.

 

Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Dr. Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Dr. Kiran Solingapuram Sai, Wake Forest School of Medicine, United States.

Dr. Kiran K. Solingapuram Sai, PhD, is an Associate Professor with tenure in the Department of Radiology at Wake Forest School of Medicine. He holds a Ph.D. in Organic Chemistry from Northern Illinois University and has extensive research experience in radiopharmaceutical chemistry. His postdoctoral training at Washington University’s Mallinckrodt Institute of Radiology focused on radiotracer development.

Profile

Orcid

 

✨ Early Academic Pursuits

Dr. Kiran K. Solingapuram Sai embarked on his academic journey with a strong foundation in chemistry, earning a Bachelor of Science degree in Chemistry, Biochemistry, and Microbiology from Osmania University, Hyderabad, India, in 2001. His passion for organic chemistry led him to pursue a Master of Science in the same field at Osmania University, where he honed his expertise in chemical synthesis and molecular interactions. Determined to explore the depths of organic chemistry, he pursued his Ph.D. at Northern Illinois University, DeKalb, IL, under the mentorship of Dr. Douglas A. Klumpp. During this period, his research focused on synthetic methodologies and organic reaction mechanisms, paving the way for his future contributions to medicinal and radiopharmaceutical chemistry.

🌐 Professional Endeavors

Dr. Sai’s professional journey commenced with a prestigious postdoctoral research associate position at the Mallinckrodt Institute of Radiology at Washington University in St. Louis, MO, where he worked under the guidance of Dr. Robert H. Mach. During his tenure from 2010 to 2013, he delved into the complexities of radiochemistry, developing novel radiotracers and exploring their applications in medical imaging. This experience laid the groundwork for his career in radiopharmaceutical sciences. In 2014, he joined Wake Forest School of Medicine as a Research Instructor and Chief Radiochemist, marking the beginning of his significant contributions to translational imaging and radiopharmaceutical production.

⚛️ Contributions and Research Focus

At Wake Forest School of Medicine, Dr. Sai played a pivotal role in the Department of Radiology and the Clinical Translational Science Institute (CTSI). He specialized in managing clinical and research-based radiopharmaceutical production at the Wake Forest PET Research Center. As a cyclotron manager and coordinator, he oversaw the synthesis and quality control of radiotracers essential for PET imaging. His expertise extended to the development and implementation of cGMP-approved protocols for C-11 and F-18 radiopharmaceutical production, ensuring the highest standards of safety and efficacy. His research focuses on advancing PET imaging techniques, exploring new radiotracers for diagnostic and therapeutic applications, and improving imaging biomarker development.

🏆 Accolades and Recognition

Dr. Sai’s dedication to radiochemistry and molecular imaging has earned him recognition in the scientific community. His work has been instrumental in developing radiopharmaceuticals for neurological and oncological imaging, contributing significantly to early disease detection and targeted therapy. His contributions have been acknowledged through numerous research grants, collaborative projects, and publications in high-impact scientific journals. His commitment to excellence and innovation has positioned him as a leading figure in the field of radiopharmaceutical sciences.

🔬 Impact and Influence

Beyond his research and technical expertise, Dr. Sai has mentored budding scientists and researchers in the field of radiochemistry and imaging sciences. His guidance has helped shape the next generation of radiopharmaceutical experts, fostering a culture of innovation and scientific curiosity. His role in translational imaging programs has bridged the gap between basic research and clinical applications, directly impacting patient care by improving diagnostic imaging techniques.

💡 Legacy and Future Contributions

Dr. Sai’s work continues to inspire advancements in molecular imaging and radiopharmaceutical development. As an Associate Professor with tenure at Wake Forest School of Medicine, he remains dedicated to pushing the boundaries of radiochemistry, developing cutting-edge imaging agents, and enhancing the precision of diagnostic medicine. His legacy in the field is defined by his unwavering commitment to scientific discovery, translational research, and the continuous pursuit of excellence in radiopharmaceutical sciences.Dr. Kiran K. Solingapuram Sai’s contributions to the field of radiopharmaceutical chemistry stand as a testament to his dedication, innovation, and impact on medical imaging and healthcare. His journey from a passionate chemistry student to a distinguished professor and researcher highlights the transformative power of science in shaping the future of medicine.

 

Publication

  1. Radiation-induced brain injury in non-human primates: A dual tracer PET study with [11C]MPC-6827 and [11C]PiB

    • Authors: Naresh Damuka, George W. Schaaf, Mack Miller, Caleb Bradley, Bhuvanachandra Bhoopal, Ivan Krizan, Krishna K. Gollapelli, Christopher T. Whitlow, J. Mark Cline, Kiran K. Solingapuram Sai
    • Year: 2025

 

  1. The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer

    • Authors: Hilal A. Rather, Sameh Almousa, Ashish Kumar, Mitu Sharma, Isabel Pennington, Susy Kim, Yixin Su, Yangen He, Abdollah R. Ghara, Kiran Kumar Solingapuram Sai et al.
    • Year: 2023

 

  1. Development and Optimization of 11C-Labeled Radiotracers: A Review of the Modern Quality Control Design Process

    • Authors: Paul Josef Myburgh, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. Binding Parameters of [11C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents

    • Authors: Avinash H. Bansode, Bhuvanachandra Bhoopal, Krishna Kumar Gollapelli, Naresh Damuka, Ivan Krizan, Mack Miller, Suzanne Craft, Akiva Mintz, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains

    • Authors: Naresh Damuka, Paul W. Czoty, Ashley T. Davis, Michael Nader, Susan H. Nader, Suzanne Craft, Shannon L. Macauley, Lindsey K. Galbo Thomma, Phillip M. Epperly, Christopher T. Whitlow et al.
    • Year: 2020

 

  1. One-pot synthesis of novel tert-butyl-4-substituted phenyl-1H-1,2,3-triazolo piperazine/piperidine carboxylates, potential GPR119 agonists

    • Authors: Nagaraju Bashetti, J.V. Shanmukha Kumar, Naresh Varma Seelam, B. Prasanna, Akiva Mintz, Naresh Damuka, Sriram Devanathan, Kiran Kumar Solingapuram Sai
    • Year: 2019

 

Conclusion

Dr. Kiran K. Solingapuram Sai has established himself as a leading expert in radiopharmaceutical sciences, contributing significantly to translational imaging research. His work in PET radiopharmaceutical production and quality assurance underscores his role in advancing medical imaging techniques. His academic and research contributions make him a valuable asset in the field of radiology and molecular imaging.